| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9008466a40998f8be8e54cd3aceb10a2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4365 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 |
| filingDate |
2012-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f167e02974484bdd1cd8417bcffe99fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf4084f211cf1f63fe09bb65c0a3c5da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cee44aaa27f1b24a073267c00f40d5b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7547cb13b69823a75750007469101bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b07ac21ec7be62f7532c1fc22270aac4 |
| publicationDate |
2018-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3345481-A1 |
| titleOfInvention |
Maintenance of platelet inhibition during antiplatelet therapy |
| abstract |
There is provided a reversible short-acting P2Y 12 inhibitor for use in a method of maintaining or reducing platelet activity in a subject undergoing an invasive procedure, wherein the reversible short-acting P2Y 12 inhibitor is cangrelor, wherein the administration of cangrelor is sufficient to reduce or maintain at least 60% platelet inhibition or PRU values less than 240 prior to the patient undergoing an invasive procedure. |
| priorityDate |
2011-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |